Frequency Caps in Pharma Programmatic: How to Set and Revisit Them
How to set pharma programmatic frequency caps as testable hypotheses with escalation triggers, instead of copying a universal benchmark.
The short answer
Frequency caps limit how many times the same person or household sees an ad in a period. Set too low, a campaign may not deliver enough repetition to be remembered. Set too high, it wastes money and can annoy people. Many teams copy a cap from a previous campaign or a benchmark. A better approach treats the cap as a hypothesis to test and revisit.
Why there is no universal cap
The right frequency depends on:
- Message complexity. A simple reminder needs fewer exposures than a new clinical concept.
- Audience size. Small audiences hit caps faster and need stricter limits.
- Channel mix. Frequency across channels adds up.
- Creative variety. More creative variants can support higher frequency with less fatigue.
- Flight length. A longer flight can spread exposures over time.
Set the cap as a hypothesis
Write it down: "We expect engagement to plateau after about six exposures per week for this HCP audience, so we will cap at six and review after two weeks."
Then watch the data:
| Signal | What it suggests |
|---|---|
| Engagement rate falls steadily with each additional exposure | Cap may be too high |
| Engagement keeps rising up to the cap | Cap may be too low |
| Most people never reach the cap | Reach, not frequency, is the constraint |
| A small group is at the cap every week | Audience is small or targeting is narrow |
Look at distribution, not averages
An average frequency of five can hide a situation where half the audience saw one ad and a few people saw 30. Ask partners for the distribution. See reach, frequency, and duplication together.
Cap across channels
Caps set within one DSP do not know about impressions from other partners. For CTV and video, household frequency can climb quickly across partners. See CTV frequency management. Where you cannot cap across partners, estimate combined frequency and set individual caps lower.
Escalation triggers
Define when to revisit the cap:
- Engagement drops more than a set amount week over week.
- Share of impressions at the cap exceeds a threshold.
- Complaints or negative feedback appear.
- New creative is added.
Frequency as protection
Frequency caps also serve as a form of suppression. See exclusions and suppression rules.
Practical takeaway
For each campaign, write the cap, the reasoning behind it, and the signals that would change it. Review the frequency distribution every two weeks.
Sources
External guidance and platform documentation change. Links were current at publication; check them again before relying on them for a decision.
Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.
New pharma programmatic breakdowns, occasionally
One email when I publish something worth reading. Benchmarks, measurement teardowns, and case studies with the caveats attached. No cadence promises, no reselling your address.
Unsubscribe any time. See the privacy policy.
Working through this decision on a real plan?
I work on health and pharma data, identity, and activation, after five years running HCP and DTC programmatic agency-side. Happy to talk through how this applies to your situation.